DE69811256D1 - Polymorphe modifikationen von dofetilid - Google Patents

Polymorphe modifikationen von dofetilid

Info

Publication number
DE69811256D1
DE69811256D1 DE69811256T DE69811256T DE69811256D1 DE 69811256 D1 DE69811256 D1 DE 69811256D1 DE 69811256 T DE69811256 T DE 69811256T DE 69811256 T DE69811256 T DE 69811256T DE 69811256 D1 DE69811256 D1 DE 69811256D1
Authority
DE
Germany
Prior art keywords
dofetilid
polymorphic modifications
polymorphic
modifications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811256T
Other languages
English (en)
Other versions
DE69811256T2 (de
Inventor
Ian Colin Appleby
Trevor Jack Newbury
Gary Nichols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ireland Pharmaceuticals
Original Assignee
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69811256(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Research and Development Co NV SA filed Critical Pfizer Research and Development Co NV SA
Application granted granted Critical
Publication of DE69811256D1 publication Critical patent/DE69811256D1/de
Publication of DE69811256T2 publication Critical patent/DE69811256T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
DE69811256T 1997-10-27 1998-10-09 Polymorphe modifikationen von dofetilid Expired - Fee Related DE69811256T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs
PCT/EP1998/006641 WO1999021829A1 (en) 1997-10-27 1998-10-09 Dofetilide polymorphs

Publications (2)

Publication Number Publication Date
DE69811256D1 true DE69811256D1 (de) 2003-03-13
DE69811256T2 DE69811256T2 (de) 2003-09-18

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811256T Expired - Fee Related DE69811256T2 (de) 1997-10-27 1998-10-09 Polymorphe modifikationen von dofetilid

Country Status (47)

Country Link
US (1) US6124363A (de)
EP (1) EP1027329B1 (de)
JP (1) JP3569495B2 (de)
KR (1) KR100366167B1 (de)
CN (1) CN1146537C (de)
AP (1) AP906A (de)
AR (1) AR015193A1 (de)
AT (1) ATE232199T1 (de)
AU (1) AU737668B2 (de)
BG (1) BG64125B1 (de)
BR (1) BR9813308A (de)
CA (1) CA2307121C (de)
CO (1) CO4970768A1 (de)
DE (1) DE69811256T2 (de)
DK (1) DK1027329T3 (de)
DZ (1) DZ2632A1 (de)
EA (1) EA002656B1 (de)
ES (1) ES2190620T3 (de)
GB (1) GB9722662D0 (de)
GT (1) GT199800165A (de)
HK (1) HK1033933A1 (de)
HN (1) HN1998000165A (de)
HR (1) HRP20000247B1 (de)
HU (1) HUP0004735A3 (de)
ID (1) ID24658A (de)
IL (1) IL135435A0 (de)
IS (1) IS2179B (de)
MA (1) MA24683A1 (de)
MY (1) MY123352A (de)
NO (1) NO325630B1 (de)
NZ (1) NZ503785A (de)
OA (1) OA11350A (de)
PA (1) PA8462001A1 (de)
PE (1) PE122199A1 (de)
PL (1) PL197379B1 (de)
PT (1) PT1027329E (de)
SA (1) SA98190834B1 (de)
SI (1) SI1027329T1 (de)
SK (1) SK5862000A3 (de)
TN (1) TNSN98193A1 (de)
TR (1) TR200001135T2 (de)
TW (1) TW449589B (de)
UA (1) UA67755C2 (de)
UY (2) UY25222A1 (de)
WO (1) WO1999021829A1 (de)
YU (1) YU24000A (de)
ZA (1) ZA989719B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ307826B6 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (de) * 1997-08-19 1999-03-03 Pfizer Inc. Methode zur Behandlung von Herzversagen

Also Published As

Publication number Publication date
TR200001135T2 (tr) 2000-09-21
GT199800165A (es) 2000-04-19
PL340805A1 (en) 2001-02-26
EP1027329A1 (de) 2000-08-16
ZA989719B (en) 2000-04-26
ATE232199T1 (de) 2003-02-15
YU24000A (sh) 2003-02-28
SK5862000A3 (en) 2001-10-08
DE69811256T2 (de) 2003-09-18
TW449589B (en) 2001-08-11
EP1027329B1 (de) 2003-02-05
CA2307121C (en) 2006-12-05
GB9722662D0 (en) 1997-12-24
CN1278246A (zh) 2000-12-27
UY25341A1 (es) 1999-09-27
OA11350A (en) 2003-12-17
IS2179B (is) 2006-12-15
UA67755C2 (uk) 2004-07-15
AU2151299A (en) 1999-05-17
CA2307121A1 (en) 1999-05-06
HRP20000247A2 (en) 2000-10-31
AR015193A1 (es) 2001-04-18
NO20002191L (no) 2000-04-27
NO20002191D0 (no) 2000-04-27
CN1146537C (zh) 2004-04-21
BR9813308A (pt) 2000-08-22
SI1027329T1 (en) 2003-04-30
JP3569495B2 (ja) 2004-09-22
HK1033933A1 (en) 2001-10-05
IS5426A (is) 2000-03-31
KR100366167B1 (ko) 2003-01-09
MA24683A1 (fr) 1999-07-01
HRP20000247B1 (en) 2002-08-31
DZ2632A1 (fr) 2003-03-08
PE122199A1 (es) 1999-12-02
PT1027329E (pt) 2003-04-30
PL197379B1 (pl) 2008-03-31
MY123352A (en) 2006-05-31
TNSN98193A1 (fr) 2005-03-15
HUP0004735A2 (hu) 2001-10-28
UY25222A1 (es) 2000-12-29
EA002656B1 (ru) 2002-08-29
WO1999021829A1 (en) 1999-05-06
AP9801371A0 (en) 1998-12-31
SA98190834B1 (ar) 2006-08-21
DK1027329T3 (da) 2003-02-24
HN1998000165A (es) 1999-02-09
PA8462001A1 (es) 2000-05-24
BG104373A (en) 2000-12-29
HUP0004735A3 (en) 2001-12-28
AU737668B2 (en) 2001-08-30
ES2190620T3 (es) 2003-08-01
CO4970768A1 (es) 2000-11-07
AP906A (en) 2000-11-30
BG64125B1 (bg) 2004-01-30
KR20010031439A (ko) 2001-04-16
JP2001521023A (ja) 2001-11-06
ID24658A (id) 2000-07-27
EA200000365A1 (ru) 2000-12-25
NZ503785A (en) 2004-11-26
US6124363A (en) 2000-09-26
NO325630B1 (no) 2008-06-30
IL135435A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69725205D1 (de) Befestigung von Biomolekülen
DE69718393T2 (de) Befestigung von Biomolekülen
FI973596A0 (fi) Identifikation av talaktiviteten av en kaella
EE200000321A (et) Uudsed ühendid
EE200000365A (et) Bispidiini uued arütmiavastased ühendid
ID24458A (id) Modifikasi rheologi in-sito poliolefin
ID22379A (id) Hidrogenasi imina enamina
DE69811256T2 (de) Polymorphe modifikationen von dofetilid
NO20002555D0 (no) Skjøt
DE69837899D1 (de) Elektrophoreseapparatur
SE9702775D0 (sv) Novel compounds
UA1821S (uk) Комплект етикеток
UA1690S (uk) Комплект етикеток
UA1663S (uk) Комплект етикеток
UA1757S (uk) Комплект етикеток
UA2115S (uk) Комплект етикеток
UA1863S (uk) Комплект етикеток
UA1828S (uk) Комплект етикеток
UA1619S (uk) Комплект етикеток
UA1758S (uk) Комплект етикеток
UA1689S (uk) Комплект етикеток
UA1829S (uk) Комплект етикеток
UA1664S (uk) Комплект етикеток

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PFIZER IRELAND PHARMACEUTICALS, DUBLIN, IE

8339 Ceased/non-payment of the annual fee